Understanding these patterns may help explain why some patients tolerate consistent weekly dosing easily while others require careful titration or alternative formulations
GLP-1s don't just suppress your appetite
By following these strategies, you can reduce the likelihood of getting a UTI, especially if youre prone to recurrent infections
Some doctors may provide it off-label for weight loss, but this is not common practice
Ill break down exactly what GHK-Cu does at the cellular level, what injectable use can realistically deliver, and what the actual research says about safety
Designed to inhibit DPP-4, the enzyme found to degrade GLP-1 (7-37), this drug, generically called sitagliptin, was developed at Merck by its first research team solely led by women